<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02322710</url>
  </required_header>
  <id_info>
    <org_study_id>LINE4002</org_study_id>
    <secondary_id>2014-A00914-43</secondary_id>
    <nct_id>NCT02322710</nct_id>
  </id_info>
  <brief_title>Comparison of Efficacy on Healing, and Safety of Two Dressings Urgotul and TulleGras MS on Surgical Acute Wounds.</brief_title>
  <official_title>Multicentre, Randomized, Parallel Group, Non-inferiority, Open-label Study Aiming at Comparing the Healing Rates (With Blinded Assessment Based on Photographs) of TULLEGRAS M.S.® With URGOTUL® in the Treatment of Surgical Acute Wounds.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mylan Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fovea</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Mylan Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluation of non-inferiority on healing rates of two dressings Urgotul and TulleGras MS in
      the treatment of surgical acute wounds.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2014</start_date>
  <completion_date type="Actual">November 2016</completion_date>
  <primary_completion_date type="Actual">November 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of patients with complete healing (100% of epithelialization).</measure>
    <time_frame>D21</time_frame>
    <description>Using photographs,independent assessor blinded assessment.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to complete healing (100% epithelialization)</measure>
    <time_frame>At each visit (D1, D21)</time_frame>
    <description>Assessment by the investigator</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of healing according to Vancouver scale</measure>
    <time_frame>D21</time_frame>
    <description>Assessment by the investigator</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frequency of painless dressing removal (pain &lt; 30 mm on 100 mm VAS)</measure>
    <time_frame>During first three removals</time_frame>
    <description>Assessment by the patient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety and tolerability of the dressings</measure>
    <time_frame>At each visit (D1, D21)</time_frame>
    <description>number of patients with adverse event as a measure of safety and tolerability</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">208</enrollment>
  <condition>Surgical Acute Wounds</condition>
  <arm_group>
    <arm_group_label>TulleGras M.S.</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Sterile dressing that consists of viscose tissue coated with mineral vaseline</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Urgotul</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Sterile, hydrocolloid dressing, that consists of a polyester fabric coated with hydrocolloid particles and vaseline</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Urgotul: Low-adherent dressing</intervention_name>
    <arm_group_label>Urgotul</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TulleGras M.S.: Vaseline gauze</intervention_name>
    <arm_group_label>TulleGras M.S.</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female subject.

          -  Aged 18 to 75 years

          -  With a planned surgery:

          -  Of abdominal location

          -  Leading to an acute wound of a maximum total length ≤ 18 cm (corresponding to 2
             investigational products)

          -  Absence of clinical sign suggestive of worsened wound (assessed only at the
             randomization visit)

          -  Followed-up in surgery department

          -  Written and signed informed consent obtained

          -  Affiliated to the French Social Security system or equivalent.

        Exclusion Criteria:

          -  Underlying pathology that may interfere with wound healing in the opinion of the
             Investigator (human immunodeficiency virus [HIV], cancer, immunodeficiency disease,
             generalized infection, systemic disease ...). The presence of low-risk prostate cancer
             according to the Amico classification (1) (PSA&lt;10 ng/mL and Gleason's score &lt; 6 and
             clinical grade T1c ou T2a) or a grade T1 (a or b) N0M0 renal cancer which requires
             surgery without adjuvant therapy (radiotherapy, chemotherapy, hormonal therapy...), in
             a patient whose general condition is preserved without significant comorbidity or
             signs of malnutrition are not considered as a non- inclusion criteria

          -  Inadequately controlled diabetes (Glycosylated hemoglobin &gt; 8%)

          -  Hypo or hyperthyroidism

          -  Intake of a systemic treatment with glucocorticoids or immunosuppressives

          -  Known allergy to one of study dressings components

          -  Participation in a clinical trial in the month prior to his/her inclusion in the study

          -  Pregnancy or breastfeeding or of childbearing potential and saying not to use
             contraception.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Roger LESAUNIER, MD</last_name>
    <role>Study Director</role>
    <affiliation>Mylan</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Research facility ID ORG-001264</name>
      <address>
        <city>Ajaccio</city>
        <zip>20303</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research facility ID ORG-001263</name>
      <address>
        <city>Angoulême</city>
        <zip>16959</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research facility ORG-001090</name>
      <address>
        <city>Athis-Mons</city>
        <zip>91200</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research facility ORG-001101</name>
      <address>
        <city>Aubervilliers</city>
        <zip>93300</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research facility ID ORG-001099</name>
      <address>
        <city>Carpentras</city>
        <zip>84200</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research facility ORG-001099</name>
      <address>
        <city>Carpentras</city>
        <zip>84200</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research facility ORG-001107</name>
      <address>
        <city>Cornebarrieu</city>
        <zip>31700</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research facility ID ORG-001223</name>
      <address>
        <city>La Rochelle</city>
        <zip>17000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research facility ORG-001096</name>
      <address>
        <city>Levallois Perret</city>
        <zip>92300</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research facility ORG-001096</name>
      <address>
        <city>Levallois-perret</city>
        <zip>92300</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research facility ID ORG-001276</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research facility ORG-001102</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research facility ORG-001360</name>
      <address>
        <city>Lyon</city>
        <zip>69003</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research facility ORG-001132</name>
      <address>
        <city>Mantes La Jolie</city>
        <zip>78200</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research facility ORG-001133</name>
      <address>
        <city>Montpellier cedex 5</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research facility ID ORG-001133</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research facility ID ORG-001220</name>
      <address>
        <city>Montreuil-sous-Bois Cedex</city>
        <zip>93105</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research facility ID ORG-001189</name>
      <address>
        <city>Nice</city>
        <zip>6002</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research facility ID ORG-001190</name>
      <address>
        <city>Ollioules</city>
        <zip>89190</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research facility ID ORG-001221</name>
      <address>
        <city>Paris Cedex 18</city>
        <zip>75877</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research facility ID ORG-001088</name>
      <address>
        <city>Paris</city>
        <zip>75008</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research facility ID ORG-001105</name>
      <address>
        <city>Paris</city>
        <zip>75008</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research facility ORG-001105</name>
      <address>
        <city>Paris</city>
        <zip>75008</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research facility ID ORG-001134</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research facility ID ORG-001265</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research facility ORG-001088</name>
      <address>
        <city>Paris</city>
        <zip>75018</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research facility ORG-001166</name>
      <address>
        <city>Pierre Benite</city>
        <zip>69495</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research facility ID ORG-001278</name>
      <address>
        <city>Reims</city>
        <zip>51090</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research facility ORG-001137</name>
      <address>
        <city>Roubaix</city>
        <zip>59100</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research facility ORG-001136</name>
      <address>
        <city>Rouen</city>
        <zip>76000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research facility ORG-001089</name>
      <address>
        <city>Saint Nazaire</city>
        <zip>44600</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research facility ID ORG-001222</name>
      <address>
        <city>Sarreguemines</city>
        <zip>57200</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research facility ORG-001097</name>
      <address>
        <city>Sarreguemines</city>
        <zip>57200</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research facility ORG-001093</name>
      <address>
        <city>Toulon</city>
        <zip>83100</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 19, 2014</study_first_submitted>
  <study_first_submitted_qc>December 19, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 23, 2014</study_first_posted>
  <last_update_submitted>December 14, 2016</last_update_submitted>
  <last_update_submitted_qc>December 14, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 15, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>non-inferiority</keyword>
  <keyword>randomized</keyword>
  <keyword>TulleGras</keyword>
  <keyword>Urgotul</keyword>
  <keyword>healing</keyword>
  <keyword>surgical acute wounds</keyword>
  <keyword>pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Petrolatum</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>April 11, 2017</submitted>
    <returned>June 23, 2017</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

